Antivirals reduce the formation of key Alzheimer's disease molecules in cell cultures acutely infected with herpes simplex virus type 1

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Wozniak, Matthew A ^a   Frost, Alison L ^a   Preston, Chris M ^b   Itzhaki, Ruth F ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMYLOID BETA PROTEIN[1-42]; BINDING PROTEIN; FOSCARNET; HOST CELL FACTOR C1; IMMEDIATE EARLY PROTEIN; OCTOMER BINDING PROTEIN 1; PENCICLOVIR; PROTEIN VP16; TAU PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA; AMYLOID BETA PROTEIN; ANTIVIRUS AGENT;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; CYTOPATHOLOGY; DNA REPLICATION; DRUG EFFECT; DRUG RECEPTOR BINDING; DRUG TARGETING; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HAMSTER; HERPES SIMPLEX VIRUS 1; IMMUNOCYTOCHEMISTRY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; VERO CELL; VIRAL PHENOMENA AND FUNCTIONS; VIRUS ASSEMBLY; VIRUS ENTRY; VIRUS FUSION; VIRUS INHIBITION; VIRUS PARTICLE; VIRUS RELEASE; VIRUS REPLICATION; VIRUS UNCOATING; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL LINE; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; TIME;

HUMAN HERPESVIRUS 1;

ACYCLOVIR; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CELLS, CULTURED; CRICETINAE; DNA REPLICATION; DNA, VIRAL; HERPESVIRUS 1, HUMAN; HUMANS; PROTEIN BIOSYNTHESIS; TAU PROTEINS; TIME FACTORS; VIRUS REPLICATION;

EID: 80053918451     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025152     Document Type: Article

References (52)

1. Ball MJ, (1982) "Limbic predilection in Alzheimer dementia: is reactivated herpesvirus involved? " Can J Neurol Sci 9: 303-306.
2. Jamieson GA, Maitland NJ, Wilcock GK, Craske J, Itzhaki RF, (1991) Latent herpes simplex virus type 1 in normal and Alzheimer's disease brains. J Med Virol 33: 224-227.
3. Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, et al. (1997) Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet 349: 241-244.
4. Itabashi S, Arai H, Matsui T, Higuchi S, Sasaki H, (1997) Herpes simplex virus and risk of Alzheimer's disease. Lancet 349: 1102.
5. Lin WR, Graham J, MacGowan SM, Wilcock GK, Itzhaki RF, (1998) Alzheimer's disease, herpes virus in brain, apolipoprotein E4 and herpes labialis. Alzheimer's Reports 1: 173-178.
6. Wozniak MA, Frost AL, Itzhaki RF, (2009) Alzheimer's disease-specific tau phosphorylation is induced by herpes simplex virus type 1. J Alzheimers Dis 16: 341-350.
7. Wozniak MA, Itzhaki RF, Shipley SJ, Dobson CB, (2007) Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation. Neurosci Lett 429: 95-100.
8. Zambrano A, Solis L, Salvadores N, Cortes M, Lerchundi R, et al. (2008) Neuronal cytoskeletal dynamic modification and neurodegeneration induced by infection with herpes simplex virus type 1. J Alzheimers Dis 14: 259-269.
9. Piacentini R, Civitelli L, Ripoli C, Elena Marcocci M, De Chiara G, et al. (2010) HSV-1 promotes Ca(2+)-mediated APP phosphorylation and Abeta accumulation in rat cortical neurons. Neurobiol Aging DOI:10.1016/j.neurobiolaging.2010.06.009.
10. Santana S, Recuero M, Bullido MJ, Valdivieso F, Aldudo J, (2011) Herpes simplex virus type I induces the accumulation of intracellular beta-amyloid in autophagic compartments and the inhibition of the non-amyloidogenic pathway in human neuroblastoma cells. Neurobiol Aging doi:10.1016/j.neurobiolaging.2010.12.010.
11. Lerchundi R, Neira R, Valdivia S, Vio K, Concha MI, et al. (2011) Tau Cleavage at D421 by Caspase-3 is Induced in Neurons and Astrocytes Infected with Herpes Simplex Virus Type 1. J Alzheimers Dis 23: 513-520.
12. De Chiara G, Marcocci ME, Civitelli L, Argnani R, Piacentini R, et al. (2010) APP processing induced by herpes simplex virus type 1 (HSV-1) yields several APP fragments in human and rat neuronal cells. PLoS One 5: e13989.
13. Ill-Raga G, Palomer E, Wozniak MA, Ramos-Fernandez E, Bosch-Morato M, et al. (2011) Activation of PKR Causes Amyloid ss-Peptide Accumulation via De-Repression of BACE1 Expression. PLoS One 6: e21456.
14. Wozniak MA, Mee AP, Itzhaki RF, (2009) Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques. J Pathol 217: 131-138.
15. Spear PG, (2004) Herpes simplex virus: receptors and ligands for cell entry. Cell Microbiol 6: 401-410.
16. O'Hare, (1993) The virion transactivator of herpes simplex virus. Seminars in Virology 4: 145-155.
17. Honess RW, Roizman B, (1974) Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J Virol 14: 8-19.
18. Everett RD, (1984) Trans activation of transcription by herpes virus products: requirement for two HSV-1 immediate-early polypeptides for maximum activity. EMBO J 3: 3135-3141.
19. DeLuca NA, Schaffer PA, (1985) Activation of immediate-early, early, and late promoters by temperature-sensitive and wild-type forms of herpes simplex virus type 1 protein ICP4. Mol Cell Biol 5: 1997-2008.
20. Johnson PA, Best MG, Friedmann T, Parris DS, (1991) Isolation of a herpes simplex virus type 1 mutant deleted for the essential UL42 gene and characterization of its null phenotype. J Virol 65: 700-710.
21. Godowski PJ, Knipe DM, (1985) Identification of a herpes simplex virus function that represses late gene expression from parental viral genomes. J Virol 55: 357-365.
22. Preston CM, Nicholl MJ, (2005) Human cytomegalovirus tegument protein pp71 directs long-term gene expression from quiescent herpes simplex virus genomes. J Virol 79: 525-535.
23. Preston CM, (1979) Control of herpes simplex virus type 1 mRNA synthesis in cells infected with wild-type virus or the temperature-sensitive mutant tsK. J Virol 29: 275-284.
24. Johnson DC, Frame MC, Ligas MW, Cross AM, Stow ND, (1988) Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gI. J Virol 62: 1347-1354.
25. Leary JJ, Wittrock R, Sarisky RT, Weinberg A, Levin MJ, (2002) Susceptibilities of herpes simplex viruses to penciclovir and acyclovir in eight cell lines. Antimicrob Agents Chemother 46: 762-768.
26. Earnshaw DL, Bacon TH, Darlison SJ, Edmonds K, Perkins RM, et al. (1992) Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus. Antimicrob Agents Chemother 36: 2747-2757.
27. Wagstaff AJ, Bryson HM, (1994) Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections. Drugs 48: 199-226.
28. Lukiw WJ, Cui JG, Yuan LY, Bhattacharjee PS, Corkern M, et al. (2010) Acyclovir or Abeta42 peptides attenuate HSV-1-induced miRNA-146a levels in human primary brain cells. Neuroreport 21: 922-927.
29. Itzhaki RF, Wozniak MA, (2008) Herpes Simplex Virus Type 1 in Alzheimer's disease: The Enemy Within. J Alzheimers Dis 13: 393-405.
30. Jamieson GA, Maitland NJ, Wilcock GK, Yates CM, Itzhaki RF, (1992) Herpes simplex virus type 1 DNA is present in specific regions of brain from aged people with and without senile dementia of the Alzheimer type. J Pathol 167: 365-368.
31. Wozniak MA, Shipley SJ, Combrinck M, Wilcock GK, Itzhaki RF, (2005) Productive herpes simplex virus in brain of elderly normal subjects and Alzheimer's disease patients. J Med Virol 75: 300-306.
32. Wozniak MA, Itzhaki RF, (2010) Antiviral agents in Alzheimer's disease: hope for the future? Therapeutic Advances in Neurological Disorders 3: 141-152.
33. Hemling N, Roytta M, Rinne J, Pollanen P, Broberg E, et al. (2003) Herpesviruses in brains in Alzheimer's and Parkinson's diseases. Ann Neurol 54: 267-271.
34. Marques AR, Straus SE, Fahle G, Weir S, Csako G, et al. (2001) Lack of association between HSV-1 DNA in the brain, Alzheimer's disease and apolipoprotein E4. J Neurovirol 7: 82-83.
35. Itzhaki RF, Dobson CB, Lin WR, Wozniak MA, (2001) Association of HSV1 and apolipoprotein E-varepsilon4 in Alzheimer's disease. J Neurovirol 7: 570-571.
36. Itzhaki RF, Dobson CB, Wozniak MA, (2004) Herpes simplex virus type 1 and Alzheimer's disease. Ann Neurol 55: 299-300; author reply 300-301.
37. Beffert U, Bertrand P, Champagne D, Gauthier S, Poirier J, (1998) HSV-1 in brain and risk of Alzheimer's disease. Lancet 351: 1330-1331.
38. Koelle DM, Magaret A, Warren T, Schellenberg GD, Wald A, (2010) APOE genotype is associated with oral herpetic lesions but not genital or oral herpes simplex virus shedding. Sex Transm Infect 86: 202-206.
39. Pulliam L, (2009) HIV regulation of amyloid beta production. J Neuroimmune Pharmacol 4: 213-217.
40. Brew BJ, Pemberton L, Blennow K, Wallin A, Hagberg L, (2005) CSF amyloid beta42 and tau levels correlate with AIDS dementia complex. Neurology 65: 1490-1492.
41. Esiri MM, Biddolph SC, Morris CS, (1998) Prevalence of Alzheimer plaques in AIDS. J Neurol Neurosurg Psychiatry 65: 29-33.
42. McQuaid S, Allen IV, McMahon J, Kirk J, (1994) Association of measles virus with neurofibrillary tangles in subacute sclerosing panencephalitis: a combined in situ hybridization and immunocytochemical investigation. Neuropathol Appl Neurobiol 20: 103-110.
43. Thompson RL, Sawtell NM, (2010) Therapeutic implications of new insights into the critical role of VP16 in initiating the earliest stages of HSV reactivation from latency. Future Med Chem 2: 1099-1105.
44. Thackray AM, Field HJ, (1996) Differential effects of famciclovir and valaciclovir on the pathogenesis of herpes simplex virus in a murine infection model including reactivation from latency. J Infect Dis 173: 291-299.
45. Thackray AM, Field HJ, (1998) Famciclovir and valaciclovir differ in the prevention of herpes simplex virus type 1 latency in mice: a quantitative study. Antimicrob Agents Chemother 42: 1555-1562.
46. Thackray AM, Field HJ, (2000) Effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice: how dissimilar are study results? J Infect Dis 181: 1517-1518.
47. Pouplin T, Pouplin JN, Van Toi P, Lindegardh N, Rogier van Doorn H, et al. (2011) Valacyclovir for herpes simplex encephalitis. Antimicrob Agents Chemother 55: 3624-3626.
48. Lycke J, Malmestrom C, Stahle L, (2003) Acyclovir levels in serum and cerebrospinal fluid after oral administration of valacyclovir. Antimicrob Agents Chemother 47: 2438-2441.
49. Dobson CB, Sales SD, Hoggard P, Wozniak MA, Crutcher KA, (2006) The receptor-binding region of human apolipoprotein E has direct anti-infective activity. J Infect Dis 193: 442-450.
50. Davison MJ, Preston VG, McGeoch DJ, (1984) Determination of the sequence alteration in the DNA of the herpes simplex virus type 1 temperature-sensitive mutant ts K. J Gen Virol 65 (Pt 5): 859-863.
51. Jamieson DR, Robinson LH, Daksis JI, Nicholl MJ, Preston CM, (1995) Quiescent viral genomes in human fibroblasts after infection with herpes simplex virus type 1 Vmw65 mutants. J Gen Virol 76: 1417-1431.
52. Ace CI, McKee TA, Ryan JM, Cameron JM, Preston CM, (1989) Construction and characterization of a herpes simplex virus type 1 mutant unable to transinduce immediate-early gene expression. J Virol 63: 2260-2269.